Ignite Creation Date:
2024-05-06 @ 10:14 AM
Last Modification Date:
2024-10-26 @ 12:26 PM
Study NCT ID:
NCT03194893
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2017-06-20
Brief Title:
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase ALK-Positive or Rearranged During Transfection RET-Positive Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-12
Completion Date Type:
ESTIMATED
First Submit Date:
2017-06-20
First Submit QC Date:
June 20 2017
Study First Post Date:
2017-06-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-02
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL